Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIENCE: Stem Cell Therapy in Ischemic Heart Failure
NCT02673164Phase 2Completed
- Sponsor
- Cell2Cure
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in heart failure (HF), sponsored by Cell2Cure. Started Jan 2017; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02673164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673164.